KLK3 and pachyonychia congenita: Prostate-specific antigen (PSA) has been commonly used as a marker for PC, but it cannot differentiate PC from benign prostatic hyperplasia (BPH) unless PC is advanced and shows much higher serum PSA levels than BPH [9, 10].